Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention
Kalemera M, Maher A, Dominguez-Villar M, Maertens G. Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention. Pharmaceuticals 2024, 17: 730. PMID: 38931397, PMCID: PMC11206710, DOI: 10.3390/ph17060730.Peer-Reviewed Original ResearchAdult T-cell leukaemia/lymphomaIntegrase strand transfer inhibitorsNucleoside reverse transcriptase inhibitorsHTLV-1Reservoir of latently infected CD4+ T cellsDevelopment of adult T-cell leukaemia/lymphomaHIV-1Latently infected CD4+ T cellsHuman T-cell lymphotropic virus type 1Infected CD4+ T cellsCD4+ T cellsHTLV-1 endemic areasAssociated with poor prognosisHTLV-1-associated pathologiesAntiretroviral therapy prescriptionT-cell leukaemia/lymphomaStrand transfer inhibitorsHTLV-1 infectionHTLV-1 transmissionReverse transcriptase inhibitorsShorter overall survivalVirus type 1HIV pillsOverall survivalHIV therapy